Close menu




Gold mine

Photo credits: pixabay.com

Commented by Lars Winter on October 20th, 2026 | 05:44 CEST

Gold, Money and Healthcare: Lahontan Gold, Goldman Sachs and Johnson & Johnson – 3 Promising Stocks Under Review

  • Gold
  • Gold mine
  • Gold price
  • Commodities
  • Precious metal
  • Mining
  • Banks
  • Financial services providers
  • Pharmaceutical industry
  • Medicines
  • Health
  • Medicine

Canadian gold exploration company Lahontan Gold is generating optimism. A preliminary economic assessment of its key mining project in Nevada recently assigned the Santa Fe Mine a calculated project value of USD 820 million. This is a multiple of its current market capitalisation, giving the stock considerable upside potential. Goldman Sachs has also surprised the market in recent days with a strong set of financial results. Pharmaceutical giant Johnson & Johnson, meanwhile, raised its outlook despite one minor setback. Three promising companies with positive news are under review.

Read

Commented by Nico Popp on October 13th, 2026 | 05:34 CEST

Nevada’s M&A Carousel Is Spinning: Newmont, Barrick Mining and Lahontan Gold Reposition Themselves

  • Gold
  • Gold mines
  • Nevada
  • Walker Lane
  • Takeovers
  • Lahontan Gold
  • Newmont
  • Barrick Mining

Within a month, the gold price fell about 7% to USD 4,136 per ounce. Despite this correction, transaction pace in Nevada's Walker Lane trend remains high. Major mining groups are using the still-attractive price level to clean up their balance sheets. At the same time, agile development companies are securing strategically important properties through targeted acquisitions. The rationale is clear: Acquiring existing ounces in the ground is often cheaper than making new discoveries. Astute investors can benefit from developments in Nevada.

Read